Related Experiment Video
Updated: Dec 23, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Reconsidering the Role of Melatonin in Rheumatoid Arthritis
Iona J MacDonald1, Chien-Chung Huang1,2, Shan-Chi Liu3
1School of Medicine, China Medical University, Taichung 40402, Taiwan.
Abstract:
Rheumatoid arthritis (RA) is an inflammatory joint disorder characterized by synovial proliferation and inflammation, with eventual joint destruction if inadequately treated. Modern therapies approved for RA target the proinflammatory cytokines or Janus kinases that mediate the initiation and progression of the disease. However, these agents fail to benefit all patients with RA, and many lose therapeutic responsiveness over time. More effective or adjuvant treatments are needed. Melatonin has shown beneficial activity in several animal models and clinical trials of inflammatory autoimmune diseases, but the role of melatonin is controversial in RA. Some research suggests that melatonin enhances proinflammatory activities and thus promotes disease activity in RA, while other work has documented substantial anti-inflammatory and immunoregulatory properties of melatonin in preclinical models of arthritis. In addition, disturbance of the circadian rhythm is associated with RA development and melatonin has been found to affect clock gene expression in joints of RA. This review summarizes current understanding about the immunopathogenic characteristics of melatonin in RA disease. Comprehensive consideration is required by clinical rheumatologists to balance the contradictory effects.
Insights
Melatonin
Area of Science:
- Immunology
- Rheumatology
- Endocrinology
Background:
- Rheumatoid arthritis (RA) is a chronic inflammatory joint disease.
- Current RA therapies target cytokines or Janus kinases but have limitations.
- Adjuvant treatments for RA are needed due to treatment resistance.
Purpose of the Study:
- To review the immunopathogenic roles of melatonin in rheumatoid arthritis.
- To analyze conflicting evidence regarding melatonin's effects in RA.
- To highlight the need for careful consideration of melatonin's use in RA management.
Main Methods:
- Literature review of preclinical and clinical studies on melatonin and RA.
- Analysis of research on melatonin's effects on inflammation and immune regulation in arthritis models.
- Examination of studies linking circadian rhythm disruption and melatonin to RA pathogenesis.
Main Results:
- Melatonin exhibits controversial effects in RA, with some studies suggesting pro-inflammatory roles and others demonstrating anti-inflammatory and immunoregulatory properties.
- Melatonin influences clock gene expression in RA joints.
- Circadian rhythm disruption is linked to RA development.
Conclusions:
- Melatonin's role in RA is complex and requires further investigation.
- Clinical rheumatologists must carefully weigh the contradictory effects of melatonin.
- Balancing melatonin's dual actions is crucial for potential therapeutic applications in RA.
Related Concept Videos
Management of Insomnia
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
The JAK-STAT Signaling Pathway
Circadian Rhythms and Gene Regulation
REM Sleep Behavior Disorder
RBD is significantly associated with...

